Search research articles
Contact Us
Filters
Showing results (11-20 of 18) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 18 results.
Tumori
|
June 12, 2025
Engagement in cancer clinical trials among a nationally representative cancer survivor sample: Motivators, barriers and opportunities for improvement
Zachary S Feuer, Richard S Matulewicz, Ramsankar Basak, et al.
Clinical Genitourinary Cancer
|
February 14, 2021
Overall Survival of Biopsy-confirmed T1B and T2A Kidney Cancers Managed With Observation: Prognostic Value of Tumor Histology
Jamie Michael, Nermarie Velazquez, Audrey Renson, et al.
Current Problems in Cancer
|
April 21, 2023
Diversity, equity, and inclusion in genitourinary clinical trials leading to FDA novel drug approval: An assessment of the FDA center for drug evaluation and research drug trials snapshot
Asia N Matthew-Onabanjo, Gabrielle Nortey, Richard S Matulewicz, et al.
Nature Medicine
|
August 7, 2025
Adjuvant nivolumab in muscle-invasive urothelial carcinoma: exploratory biomarker analysis of the randomized phase 3 CheckMate 274 trial
Matthew D Galsky, Dean F Bajorin, Yoshihiko Tomita, et al.
JAMA Oncology
|
August 26, 2021
Effect of Cisplatin and Gemcitabine With or Without Berzosertib in Patients With Advanced Urothelial Carcinoma: A Phase 2 Randomized Clinical Trial
Sumanta K Pal, Paul H Frankel, Amir Mortazavi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 8, 2020
EV-101: A Phase I Study of Single-Agent Enfortumab Vedotin in Patients With Nectin-4-Positive Solid Tumors, Including Metastatic Urothelial Carcinoma
Jonathan Rosenberg, Srikala S Sridhar, Jingsong Zhang, et al.
Clinical Genitourinary Cancer
|
February 5, 2026
Real-World Outcomes of Patients With Baseline Neuropathy and/or Diabetes Mellitus Receiving Enfortumab Vedotin-Based Regimens for Advanced Urothelial Carcinoma in the UNITE Database
Albert Jang, Tanya Jindal, Ali Raza Khaki, et al.
CA: a Cancer Journal for Clinicians
|
December 13, 2025
Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert consensus on the management of renal cell and urinary tract cancers
Rana R McKay, Sumanta Pal, Wanling Xie, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 18) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 18 results.
Tumori
|
June 12, 2025
Engagement in cancer clinical trials among a nationally representative cancer survivor sample: Motivators, barriers and opportunities for improvement
Zachary S Feuer, Richard S Matulewicz, Ramsankar Basak, et al.
Clinical Genitourinary Cancer
|
February 14, 2021
Overall Survival of Biopsy-confirmed T1B and T2A Kidney Cancers Managed With Observation: Prognostic Value of Tumor Histology
Jamie Michael, Nermarie Velazquez, Audrey Renson, et al.
Current Problems in Cancer
|
April 21, 2023
Diversity, equity, and inclusion in genitourinary clinical trials leading to FDA novel drug approval: An assessment of the FDA center for drug evaluation and research drug trials snapshot
Asia N Matthew-Onabanjo, Gabrielle Nortey, Richard S Matulewicz, et al.
Nature Medicine
|
August 7, 2025
Adjuvant nivolumab in muscle-invasive urothelial carcinoma: exploratory biomarker analysis of the randomized phase 3 CheckMate 274 trial
Matthew D Galsky, Dean F Bajorin, Yoshihiko Tomita, et al.
JAMA Oncology
|
August 26, 2021
Effect of Cisplatin and Gemcitabine With or Without Berzosertib in Patients With Advanced Urothelial Carcinoma: A Phase 2 Randomized Clinical Trial
Sumanta K Pal, Paul H Frankel, Amir Mortazavi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 8, 2020
EV-101: A Phase I Study of Single-Agent Enfortumab Vedotin in Patients With Nectin-4-Positive Solid Tumors, Including Metastatic Urothelial Carcinoma
Jonathan Rosenberg, Srikala S Sridhar, Jingsong Zhang, et al.
Clinical Genitourinary Cancer
|
February 5, 2026
Real-World Outcomes of Patients With Baseline Neuropathy and/or Diabetes Mellitus Receiving Enfortumab Vedotin-Based Regimens for Advanced Urothelial Carcinoma in the UNITE Database
Albert Jang, Tanya Jindal, Ali Raza Khaki, et al.
CA: a Cancer Journal for Clinicians
|
December 13, 2025
Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert consensus on the management of renal cell and urinary tract cancers
Rana R McKay, Sumanta Pal, Wanling Xie, et al.
Page
of 2